Tempus AI’s planned acquisition follows recent interest in blood-based cancer tests across the medtech industry.

Venture capital funding deals worth $100 million or more made up nearly half of all money invested so far this year, according to Rock Health.

Medtronic bought the pain company to expand in neuromodulation, one of its areas of strategic focus and investment.

The cyberattack follows Abbott’s recent $21 billion purchase of Exact Sciences. Abbott did not disclose what kind of ...

Intuitive on Thursday said growth in the number of U.S. procedures performed with its da Vinci surgical robots softened in the second quarter due in part to the expiration of enhanced Affordable Care ...

DePuy expects the technology, which doesn’t use screws, will strengthen its spine business and integrate into its Velys ...

The Exact Sciences acquisition, which closed in March, fueled more than 40% growth in Abbott’s diagnostics sales in the ...

Zimmer Biomet said Tuesday it has appointed Chintan Desai president of its Asia Pacific region, effective immediately. Desai ...

The robot developer’s board set a July 21 date for shareholders to vote on a proposal to wind down operations amid ...